Trevi Therapeutics Inc. (TRVI)

Market Closed

1 Sep, 20:00

NASDAQ (NMS)

16. 57

-0.03

-0.1807%

After Hours

17. 42

+0.85 +5.1298%

2.36B Market Cap

- P/E Ratio

- Div Yield

945,049 Volume

-0.39 Eps

$ 16.6

Previous Close

Investors:

Analysts:

Day Range

16.32 16.73

Year Range

6.93 20.22

Want to track TRVI and more in your Portfolio? 🎯

Trevi Therapeutics Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Curtis Burkholder Bare Financial Services, Inc	30	$358	$547.5	$189.5	52.93%
SAM Smartleaf Asset Management LLC Smartleaf Asset Management LLC	1	$9.15	$17.73	$8.58	93.77%
Winfried Buchbauer Erste Asset Management GmbH	90,000	$1.15M	$1.64M	$488,700	42.36%
Mark Schafer Police & Firemen's Retirement System of New Jersey	31,611	$292,757.53	$576,900.75	$284,143.22	97.06%
Matthew Okkerse Dauntless Investment Group LLC	1	$19	$17.73	-$1.27	-6.68%
BCG BIT Capital GmbH BIT Capital GmbH	45,000	$563,400	$797,850	$234,450	41.61%
CW Chung Wu Chung Wu Investment Group LLC	2,000	$13,760	$36,500	$22,740	165.26%
AH Anders Hove Acorn Capital Advisors LLC	2.14M	$9.15M	$39.59M	$30.45M	332.78%
BM Berkeley Meredith Hughes Financial Services LLC	4	$54.75	$73	$18.25	33.33%
Yuen Man Lee Persistent Asset Partners Ltd.	25,601	$320,524.74	$473,874.51	$153,349.77	47.84%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	2,717	$17,944.31	$50,291.67	$32,347.36	180.27%
JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH	34,554	$412,229.68	$630,610.5	$218,380.82	52.98%